Intellia Therapeutics clinical trials we track

Check company identity source

Phase 3 3 trials

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters
A Phase 3 Study of NTLA-2001 in ATTRv-PN

NCT06672237 · Intellia Therapeutics

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 60 participants (planned). After: 67 participants (actual).

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

· 4 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 60 participants (planned). After: 80 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Apr 2026. After: 10 Feb 2026.

Check registry source
A Phase 3 Study of NTLA-2001 in ATTRv-PN

NCT06672237 · Intellia Therapeutics

· 2 fields changed

Planned enrollment increased by 10 participants

Before: 50 participants (planned). After: 60 participants (planned).

Recruitment status changed

Before: Active not recruiting. After: Recruiting.

Check registry source